ObsEva SA. chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.06
Dividend & YieldN/A$ (N/A)
Beta 0.46
Market capitalization 15.72M
Operating cash flow -56.17M
ESG Scores unknown

Company description

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio2.7
Working Capital-1.46
Return On Equity-1.81
Debt To Equity0.8
Fixed Asset Ratio0.37
Fixed Interest Cover-17.27

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -16k 5.5M 2.14M -2.22M
Total Cashflows From Investing Activities -271k -5.05M -5k 22.19M
Net Borrowings -571k -571k -630k -2.44M
Total Cash From Financing Activities 91.65M 26.63M 32.25M 71.1M
Change To Operating Activities 4.14M -1.27M -1.2M 3.7M
Issuance Of Stock 98.53M 3.4M 37.25M 75.34M
Net Income -76.72M -108.79M -82.97M -58.38M
Change In Cash 27.8M -69.27M -38.19M 23.55M
Effect Of Exchange Rate 359k -240k 335k 565k
Total Cash From Operating Activities -63.94M -90.61M -70.77M -70.3M
Depreciation 109k 737k 721k 736k
Change To Account Receivables -96k 193k 326k -3.2M
Other Cashflows From Financing Activities -6.88M 23.8M -4.38M -1.8M
Change To Netincome 8.64M 13.02M 10.21M -10.94M
Capital Expenditures -188k -46k -5k -14k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 62.87M 88.05M 67.54M 53.14M
Income Before Tax -76.76M -108.72M -82.93M -58.16M
Net Income -76.72M -108.79M -82.97M -58.38M
Selling General Administrative 14.3M 19.06M 12.18M 21.49M
Gross Profit
Ebit -77.15M -107.09M -79.7M -54.51M
Operating Income -77.15M -107.09M -79.7M -54.51M
Interest Expense -1.19M -1.19M -2.7M -3.16M
Income Tax Expense -45k 67k 34k 212k
Total Revenue
Cost Of Revenue
Total Other Income ExpenseNet 393k -1.63M -3.23M -3.65M
Net Income From Continuing Ops -76.72M -108.79M -82.97M -58.38M
Net Income Applicable To Common Shares -76.72M -108.79M -82.97M -58.38M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 20.52M 54.99M 57.09M 56.65M
Total Stockholder Equity 146.92M 48.95M 8.35M 32.34M
Other Current Liabilities 2.77M 8.43M 10.76M 9.04M
Total Assets 167.44M 103.94M 65.45M 88.99M
Common Stock 3.42M 3.5M 4.57M 6.49M
Other Current Assets
Retained Earnings -183.93M -297.41M -379.39M -436.98M
Treasury Stock 12.86M 21.91M 26.35M 32.2M
Cash 138.64M 69.37M 31.18M 54.73M
Total Current Liabilities 16.93M 19.47M 21.7M 23.51M
Other Stockholder Equity 12.86M 21.91M 26.35M 32.2M
Property, Plant, and Equipment 319k 2.29M 1.58M 683k
Total Current Assets 145.24M 74.77M 36.97M 63.52M
Net Tangible Assets 125.31M 22.35M -18.25M 7.84M
Net Receivables 885k 1.04M 397k 3.56M
Accounts Payable


Insider Transactions

Here are the insider transactions of stock shares related to ObsEva SA.:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ObsEva SA.. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ObsEva SA.

Here is the result of two systematic investment strategies applied to ObsEva SA.. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ObsEva SA.

The following chart shows the equity curve of the two systematic investment strategies applied to ObsEva SA.:

ObsEva SA. automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -25.36% on the backtest period.

Performance at glance

Performance

-25.36 %

Latent gain

-571.38 $

Invested capital

2253.48 $

Annualized return

-6.13 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ObsEva SA.

This is the result of two momentum investment strategies applied to ObsEva SA.. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ObsEva SA.

The following chart shows all the entries opened by the momentum investment system on ObsEva SA.:

ObsEva SA. momentum entries
  • The first momentum investment strategy would give -23.75% of return on ObsEva SA.. That represents -1133.19$ of latent gain with 4771.44$ of employed capital.
  • The second momentum investment strategy would give -36.45% of return on ObsEva SA.. That represents -1553.64$ of latent gain with 4262.64$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-23.75 %

Latent gain

-1133.19 $

Invested capital

4771.44 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-36.45 %

Latent gain

-1553.64 $

Invested capital

4262.64 $

Annualized return

-9.96 %

Momentum equity curve on ObsEva SA.

The following chart shows the equity curve of the two momentum strategies applied to ObsEva SA.:

ObsEva SA. momentum equity

Note: the dividends potentially given by ObsEva SA. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ObsEva SA.

The following chart shows the employed capital evolution of the two momentum strategies on ObsEva SA. since the beginning:

ObsEva SA.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on ObsEva SA.

Buy the dip entry openings on ObsEva SA.

ObsEva SA.

The performance achieved by the robo-advisor on ObsEva SA. is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows ObsEva SA. stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ObsEva SA., and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to ObsEva SA.

The following chart shows the result of the investment strategy applied to ObsEva SA.:

ObsEva SA.

Note: the dividends potentially given by ObsEva SA. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ObsEva SA.

The following chart shows the employed capital evolution since the beginning of the investment strategy on ObsEva SA.:

ObsEva SA.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ObsEva SA.

In this section, I will compare the three previous investment strategies applied to ObsEva SA..

Equity curve comparison on ObsEva SA.

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ObsEva SA. investment strategy comparison

Employed capital comparison on ObsEva SA.

ObsEva SA. investment comparison

Performance comparison on ObsEva SA.

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -25.36% -571.38$ 2253.48$ -6.13%
Momentum 1 quarter -23.75% -1133.19$ 4771.44$ -6.09%
Momentum 2 quarters -36.45% -1553.64$ 4262.64$ -9.96%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-6.13 %

Momentum 1Q

-9.96 %

Momentum 2Q

-9.96 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ObsEva SA.:

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

  • JINSHANG BANK

  • Note: The algorithm computes the probability of correlation between ObsEva SA. and the other stocks. There may be false positives or some missing correlated stocks. If the price of ObsEva SA. does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name ObsEva SA.
    Country Switzerland
    City Geneva
    Address Chemin des Aulx, 12
    Phone 41 22 552 38 40
    Website www.obseva.com
    FullTime employees 48
    Industry Biotechnology
    Sector Healthcare
    Exchange XNAS
    Ticker OBSV
    Market www.nasdaq.com

    ObsEva SA. ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown